A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...

Study uncovers how the protein hnRNP A1 may impact myelin stability, offering new clues in schizophrenia development.

This week's Guest Voice features Aranzazu Calzado, who says she was terrified to learn she had MS. Today, she's proud of her ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.